Your browser doesn't support javascript.
loading
A high-fat diet and NAD(+) activate Sirt1 to rescue premature aging in cockayne syndrome.
Scheibye-Knudsen, Morten; Mitchell, Sarah J; Fang, Evandro F; Iyama, Teruaki; Ward, Theresa; Wang, James; Dunn, Christopher A; Singh, Nagendra; Veith, Sebastian; Hasan-Olive, Md Mahdi; Mangerich, Aswin; Wilson, Mark A; Mattson, Mark P; Bergersen, Linda H; Cogger, Victoria C; Warren, Alessandra; Le Couteur, David G; Moaddel, Ruin; Wilson, David M; Croteau, Deborah L; de Cabo, Rafael; Bohr, Vilhelm A.
Afiliação
  • Scheibye-Knudsen M; Laboratory of Molecular Gerontology, National Institute on Aging, National Institutes of Health, Baltimore, MD 21224, USA.
  • Mitchell SJ; Translational Gerontology Branch, National Institute on Aging, National Institutes of Health, Baltimore, MD 21224, USA; Sydney Medical School, University of Sydney, Sydney, NSW 2006, Australia.
  • Fang EF; Laboratory of Molecular Gerontology, National Institute on Aging, National Institutes of Health, Baltimore, MD 21224, USA.
  • Iyama T; Laboratory of Molecular Gerontology, National Institute on Aging, National Institutes of Health, Baltimore, MD 21224, USA.
  • Ward T; Translational Gerontology Branch, National Institute on Aging, National Institutes of Health, Baltimore, MD 21224, USA.
  • Wang J; Laboratory of Molecular Gerontology, National Institute on Aging, National Institutes of Health, Baltimore, MD 21224, USA.
  • Dunn CA; Laboratory of Molecular Gerontology, National Institute on Aging, National Institutes of Health, Baltimore, MD 21224, USA.
  • Singh N; Laboratory of Clinical Investigation, National Institute on Aging, National Institutes of Health, Baltimore, MD 21224, USA.
  • Veith S; Molecular Toxicology Group, Department of Biology, University of Konstanz, D-78457 Konstanz, Germany.
  • Hasan-Olive MM; Laboratory of Neurosciences, National Institute on Aging, National Institutes of Health, Baltimore, MD 21224, USA.
  • Mangerich A; Molecular Toxicology Group, Department of Biology, University of Konstanz, D-78457 Konstanz, Germany.
  • Wilson MA; Laboratory of Neurosciences, National Institute on Aging, National Institutes of Health, Baltimore, MD 21224, USA.
  • Mattson MP; Laboratory of Neurosciences, National Institute on Aging, National Institutes of Health, Baltimore, MD 21224, USA.
  • Bergersen LH; The Brain and Muscle Energy Group - Synaptic Neurochemistry Laboratory, Department of Anatomy, Institute of Basic Medical Sciences, University of Oslo, 0317 Oslo, Norway; Danish Center for Healthy Aging, ICMM, University of Copenhagen, Copenhagen, Denmark.
  • Cogger VC; Sydney Medical School, University of Sydney, Sydney, NSW 2006, Australia; Centre for Education and Research on Ageing and ANZAC Research Institute, Concord Hospital and University of Sydney, Sydney, NSW 2139, Australia.
  • Warren A; Centre for Education and Research on Ageing and ANZAC Research Institute, Concord Hospital and University of Sydney, Sydney, NSW 2139, Australia.
  • Le Couteur DG; Sydney Medical School, University of Sydney, Sydney, NSW 2006, Australia; Centre for Education and Research on Ageing and ANZAC Research Institute, Concord Hospital and University of Sydney, Sydney, NSW 2139, Australia.
  • Moaddel R; Laboratory of Clinical Investigation, National Institute on Aging, National Institutes of Health, Baltimore, MD 21224, USA.
  • Wilson DM; Laboratory of Molecular Gerontology, National Institute on Aging, National Institutes of Health, Baltimore, MD 21224, USA.
  • Croteau DL; Laboratory of Molecular Gerontology, National Institute on Aging, National Institutes of Health, Baltimore, MD 21224, USA.
  • de Cabo R; Translational Gerontology Branch, National Institute on Aging, National Institutes of Health, Baltimore, MD 21224, USA. Electronic address: decabora@grc.nia.nih.gov.
  • Bohr VA; Laboratory of Molecular Gerontology, National Institute on Aging, National Institutes of Health, Baltimore, MD 21224, USA; Danish Center for Healthy Aging, ICMM, University of Copenhagen, Copenhagen, Denmark. Electronic address: vbohr@nih.gov.
Cell Metab ; 20(5): 840-855, 2014 Nov 04.
Article em En | MEDLINE | ID: mdl-25440059
Cockayne syndrome (CS) is an accelerated aging disorder characterized by progressive neurodegeneration caused by mutations in genes encoding the DNA repair proteins CS group A or B (CSA or CSB). Since dietary interventions can alter neurodegenerative processes, Csb(m/m) mice were given a high-fat, caloric-restricted, or resveratrol-supplemented diet. High-fat feeding rescued the metabolic, transcriptomic, and behavioral phenotypes of Csb(m/m) mice. Furthermore, premature aging in CS mice, nematodes, and human cells results from aberrant PARP activation due to deficient DNA repair leading to decreased SIRT1 activity and mitochondrial dysfunction. Notably, ß-hydroxybutyrate levels are increased by the high-fat diet, and ß-hydroxybutyrate, PARP inhibition, or NAD(+) supplementation can activate SIRT1 and rescue CS-associated phenotypes. Mechanistically, CSB can displace activated PARP1 from damaged DNA to limit its activity. This study connects two emerging longevity metabolites, ß-hydroxybutyrate and NAD(+), through the deacetylase SIRT1 and suggests possible interventions for CS.
Assuntos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Síndrome de Cockayne / Senilidade Prematura / Sirtuína 1 / Dieta Hiperlipídica / NAD Limite: Animals / Humans Idioma: En Ano de publicação: 2014 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Síndrome de Cockayne / Senilidade Prematura / Sirtuína 1 / Dieta Hiperlipídica / NAD Limite: Animals / Humans Idioma: En Ano de publicação: 2014 Tipo de documento: Article